An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica FDA Moves to Reevaluate Several Peptides American Med Spa Association The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide Law: A Healthcare Attorney's Guide to the FD&C Act and Unapproved Drugs Holt Law